Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by CHO, M.
Right arrow Articles by BUCKPITT, A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by CHO, M.
Right arrow Articles by BUCKPITT, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1994 Oxford University Press

research-article

Reactive Naphthalene Metabolite Binding to Hemoglobin and Albumin

MYUNG CHO*, RYSZARD JEDRYCHOWSKI{dagger},{ddagger}, BRUCE HAMMOCK{ddagger} and ALAN BUCKPITT*,§,1

*Department of Pharmacology and Toxicology, School of Veterinary Medicine Davis, California 95616 {dagger}Institute of Occupational Medicine, Lodz Poland {ddagger}Department of Entomology. Agricultural and Environmental Sciences Davis, California 95616 §Occupational and Environmental Health Unit, University of California at Davis Davis, California 95616

Received January 19, 1993; accepted August 13, 1993

Earlier work has shown that the murine Clara cell cytotoxi cant, naphthalene, is metabolized to reactive metabolites which deplete glutathione or, in the absence of sufficient glutathione, become bound covalently to tissue macromolecules. Correlations between bound metabolite levels in the lung with injury suggests an association between reactive metabolite binding and toxicity. In this study we examine the formation of covalent naphthalene adducts with hemoglobin and albumin in mice to determine whether these serve as useful indices of exposure and metabolism for a chemical which shows a glutathione threshold. Covalent binding of radioactivity from [3]naphthalene to both albumin and hemoglobin was dose dependent and a glutathione threshold was observed. At early times after naphthalene administration, the formation of albumin adducts was 10- to 30-fold higher than that of hemoglobin adducts. Hemoglobin and albumin adduct levels decreased by apparent first-order processes with half-lives of 11.5 and 1.8 days, respectively. These half-lives are consistent with the turnover of these blood proteins in the mouse. Pretreatment with buthionine sulfoximine resulted in higher levels of albumin adduct but in no alteration of hemoglobin adduct levels in comparison with control. In contrast, diethylmaleate pretreatment increased the level of hemoglobin adduct but not albumin adduct. The antibody to naphthalene mercapturates recognized the hemoglobin adduct(s) but not the albumin adduct(s). Comparison of the data from ELISA (standardized using hydroxymercaptodihydronaphthalene) and radiochemical analysis yielded curves with identical slopes; the absolute levels of adduct found by ELISA were approximately half those measured with radiochemical techniques. These studies indicate that high levels of reactive naphthalene metabolites are bound to hemoglobin and albumin at doses above the glutathione threshold. Although hemoglobin adduct levels can be monitored sensitively with ELISA, the presence of the glutathione threshold suggests that monitoring exposed populations may not provide a useful measure of exposure at environmentally relevant exposure levels.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.